BioAxone BioSciences, Inc.

BioAxone is a private biotechnology company focused on the development of innovative drugs to restore neurological function and improve quality of life after spinal cord injury and other forms of neurotrauma.

Our lead product, Cethrin™, is a proprietary biologic drug designed to reduce paralysis after spinal cord injury. Phase I/IIa clinical results show that Cethrin holds enormous promise for promoting meaningful recovery after spinal cord injury and safely advancing the road to repair.